BEHRENS M KATHLEEN 4
4 · Sarepta Therapeutics, Inc. · Filed Mar 11, 2025
Insider Transaction Report
Form 4
BEHRENS M KATHLEEN
Director
Transactions
- Award
Stock Option (right to buy)
2025-03-10+4,792→ 4,792 totalExercise: $99.69From: 2026-03-10Exp: 2035-03-10→ Common Stock (4,792 underlying) - Award
Common Stock
2025-03-10+2,383→ 193,476 total
Holdings
- 10,000(indirect: By Trust)
Common Stock
Footnotes (1)
- [F1]The Reporting Person was granted restricted stock units ("RSUs"). Each RSU represents the right to receive one share of common stock. The RSUs will vest in full on March 10, 2026.